Skip to main navigation Skip to search Skip to main content

Response to Canakinumab Treatment Is Maintained in Systemic Juvenile Idiopathic Arthritis Patients.

  • N. M. Wulffraat
  • , N. Ruperto
  • , H. I. Brunner
  • , S. Oliveira
  • , Y. Uziel
  • , K. Nistala
  • , R. Cimaz
  • , M. Ferrandiz
  • , B. Flato
  • , M. L. Gamir
  • , I. Kone-Paut
  • , C. Gaillez
  • , K. Lheritier
  • , K. Abrams
  • , A. Martini
  • , D. J. Lovell

Research output: Contribution to journalMeeting AbstractAcademic

Original languageEnglish
Pages (from-to)S413-S414
JournalArthritis & Rheumatology
Volume66
Publication statusPublished - Oct 2014

Cite this